Ticker Details
Capricor Therapeutics, Inc. Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.
IPO Date:	March 1, 2007
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$546.51M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 4.77%
Avg Daily Range (30 D):	$0.89 | 10.06%
Avg Daily Range (90 D):	$0.90 | 5.57%

Institutional Daily Volume
Avg Daily Volume:	.88M
Avg Daily Volume (30 D):	10.09M
Avg Daily Volume (90 D):	4.16M

Trade Size
Avg Trade Size (Sh.):	162
Avg Trade Size (Sh.) (30 D):	135
Avg Trade Size (Sh.) (90 D):	113

Institutional Trades
Total Institutional Trades:	750
Avg Institutional Trade:	$2.05M
Avg Institutional Trade (30 D):	$1.58M
Avg Institutional Trade (90 D):	$2.84M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.54M
Avg Closing Trade (30 D):	$2.35M
Avg Closing Trade (90 D):	$3.86M
Avg Closing Volume:	153.59K

News

Sep 4, 2026 @ 9:35 PM CAPR 最終截止日期：... Source: Rosen Law Firm

Sep 4, 2026 @ 9:35 PM CAPR FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSE... Source: Rosen Law Firm

Sep 4, 2026 @ 9:09 PM Build-A-Bear Investor News: If You Have Suffered L... Source: Rosen Law Firm

Sep 3, 2026 @ 2:48 PM CAPR Investors Have Opportunity to Lead Capricor T... Source: Schall, Brown & Schwartz Llp

Sep 2, 2026 @ 10:59 PM Hagens Berman Alerts Capricor Therapeutics, Inc. (... Source: Hagens Berman Sobol Shapiro Llp

Financials
	TTM	Q1 2026	Q3 2025
Basic EPS	$-.7	$-.59	$-.54
Diluted EPS	$-.7	$-.59	$-.54
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-40.73M	$-33.94M	$-24.57M
Operating Income / Loss	$-42.95M	$-36.77M	$-26.28M
Cost of Revenue
Net Cash Flow	$-84.49M	$-182.43M	$-3.73M
PE Ratio

Splits
Jun 05, 2019	1:10
Nov 21, 2013	1:50
Feb 09, 2007	1:10
Apr 05, 2005	1:20